Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COXFA4P5 is a pseudogene annotated as related to the protein-coding gene Cytochrome c oxidase-associated subunit FA4 (COXFA4). Pseudogenes are genomic sequences that resemble known genes but have lost their protein-coding capability due to mutations and typically lack biological function. COXFA4P5 does not encode a functional protein and is not recognized as a pharmacological or clinical target. Its parent gene, COXFA4 (previously NDUFA4), is a structural subunit of Cytochrome c oxidase (Complex IV of the mitochondrial electron transport chain), with pathogenic mutations in the parent gene being associated with mitochondrial disorders such as Leigh syndrome[1][2][3][5]. However, COXFA4P5 itself is not functionally implicated in these contexts and does not serve as a disease biomarker or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase-associated subunit FA4 pseudogene 5 (COXFA4P5).